Skip to content

News Category: Health & Medical

Alphyn Biologics Announces Enrollment Passes Halfway Point in Phase2a Clinical Trial of Mild-to-Moderate Atopic Dermatitis Treatment

By asianet

–Study evaluates AB-101a for patients with and without concurrent bacterial infection Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3680049-1&h=958198912&u=https%3A%2F%2Falphynbiologics.com%2F&a=Alphyn+Biologics ), a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today that enrollment in its Phase2a clinical trial of AB-101a for mild-to-moderate atopic dermatitis (AD) has passed the halfway point. The randomized, vehicle-controlled, double-blind trial is evaluating AB-101a for the … Continued

CSafe Continues Expansion of Its Temperature-Controlled Shipping Solutions Portfolio with Introduction of Advanced Reusable Pallet Shipper

By asianet

— Loaded with innovation and technology, CSafeAPS provides superior temperature control and the industry’s only in-transit thermal capacity indicator CSafe ( https://c212.net/c/link/?t=0&l=en&o=3680585-1&h=2567441145&u=https%3A%2F%2Fcsafeglobal.com%2F&a=CSafe ), the largest provider of a complete range of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, announced today the launch of its new advanced reusable pallet shipper, CSafeAPS ( https://c212.net/c/link/?t=0&l=en&o=3680585-1&h=390496093&u=https%3A%2F%2Fhubs.li%2FQ01pZt6d0&a=CSafeAPS … Continued

EditForce Realizes RNA-editing Technology of “U-to-C”

By asianet

EditForce, Inc. (hereinafter “EditForce”), headquartered in Fukuoka, Japan, has realized the world’s first RNA-editing technology that enables RNA-editing bases to be changed from “U” to “C,” and demonstrated that this technology works even in human cells in a joint study with Professor Takahiro Nakamura, Faculty of Agriculture, Kyushu University. The study opens up the possibility … Continued

World Health Summit kicks off with German Chancellor Scholz, numerous Government Officials, WHO Director-General Tedros

By asianet

Global health in focus The World Health Summit 2022, the world’s leading meeting for global health, began on Sunday morning in Berlin. For the first time it is co-hosted by the World Health Organization (WHO). Among the central topics are climate change and health, pandemic preparedness, sustainable health systems and the role of the G7 … Continued

Tianfu International Biocity: Build Global Bioindustry-city

By asianet

On Oct.10, Chengdu Tianfu Global International Biocity saw the signing of ten project agreements totalling nearly 9B CNY in value and covering modern biopharmaceuticals, innovative chemical drugs, sophisticated medical apparatuses and other important fields. Geneseeq, a Chinese genetic disease testing giant, intends to invest in a local facility and industrialization base of genetic infection and … Continued

Menarini Silicon Biosystems’s CELLSEARCH(R) CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination

By asianet

These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 Circulating Tumor Cell (CTC-HER2) assays, to monitor disease status in patients with life-threatening illnesses. Menarini Silicon Biosystems (MSB), Inc. [https://www.siliconbiosystems.com/en-us/] is announcing that the AMA has issued Current Procedural Terminology (CPT(R)) Proprietary Laboratory Analyses (PLA) … Continued

Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants

By asianet

— Homologous boosting with the prototype Novavax COVID-19 vaccine induced robust antibody titers for Omicron BA.1, BA.2, and BA.5 — Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the consistency of the manufacturing process — A durable immunogenicity response was observed following primary … Continued

Ascend continues broad expansion into new markets, launches HiDura(TM) MED portfolio

By asianet

Ascend Performance Materials today announced a new portfolio of medical grade nylon 6,6 resins and engineered materials for the healthcare market under its HiDura( https://c212.net/c/link/?t=0&l=en&o=3673437-1&h=3917527930&u=https%3A%2F%2Fwww.ascendmaterials.com%2Fmarkets%2Fhealthcare%2F&a=HiDura )(TM) brand. Photo – https://mma.prnewswire.com/media/1918439/HiDuraMed.jpg Logo – https://mma.prnewswire.com/media/1326397/ASCEND_Logo.jpg HiDura(TM) MED products meet ISO 10993-5 and 10993-10 testing criteria and can be used in a variety of healthcare applications, including: — … Continued

CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market

By asianet

— CSafe joins BioLife’s global partner network of cold chain solution providers using the evo (R) cold chain management platform CSafe, one of the largest active and passive temperature-controlled shipping solutions providers for pharmaceuticals, and BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy … Continued